NeueHealth (NYSE:NEUE) Posts Quarterly Earnings Results

NeueHealth (NYSE:NEUE) announced its quarterly earnings results on Thursday. The company reported ($7.41) EPS for the quarter, missing the consensus estimate of ($2.29) by ($5.12), Zacks reports. NeueHealth had a negative net margin of 36.28% and a negative return on equity of 6.40%.

NeueHealth Price Performance

NeueHealth stock traded up $0.42 during trading hours on Thursday, reaching $5.26. The stock had a trading volume of 10,596 shares, compared to its average volume of 19,330. The company has a market cap of $43.58 million, a price-to-earnings ratio of -0.10 and a beta of 0.56. The business’s 50 day moving average price is $7.11 and its 200-day moving average price is $6.00. NeueHealth has a 52 week low of $3.79 and a 52 week high of $7.66.

Insider Activity

In other news, CFO Jay Matushak sold 4,970 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the sale, the chief financial officer now owns 17,747 shares in the company, valued at approximately $130,085.51. This represents a 21.88 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO George Lawrence Mikan III sold 31,798 shares of the business’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total value of $233,079.34. Following the transaction, the chief executive officer now owns 146,539 shares in the company, valued at approximately $1,074,130.87. This trade represents a 17.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 110,033 shares of company stock worth $774,560. Corporate insiders own 64.30% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada cut their target price on shares of NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research report on Monday, December 9th.

About NeueHealth

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.